SCHEDULE: Vanguard Group Amends Elevance Health Ownership

The Vanguard Group filed an Amendment No. 11 to Schedule 13G for Elevance Health Inc., reporting 0% beneficial ownership due to an internal realignment.

Summary

• The Vanguard Group filed an Amendment No. 11 to its Schedule 13G for Elevance Health Inc.
• The filing reports that The Vanguard Group now holds 0% beneficial ownership of Elevance Health Inc. common stock.
• This change is a result of an internal realignment within The Vanguard Group, effective January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will report beneficial ownership separately.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update, reflecting an internal reporting change by The Vanguard Group rather than a change in investment strategy or a direct commentary on Elevance Health Inc.'s performance.

Positives

• The internal realignment within The Vanguard Group ensures disaggregated reporting, potentially offering clearer insights into specific subsidiary holdings in the future.

Negatives

• The Vanguard Group, Inc. no longer directly reports beneficial ownership of Elevance Health Inc. common stock, which might initially appear as a divestment if not understood in the context of the internal realignment.

Risks

• Misinterpretation of the 0% beneficial ownership by The Vanguard Group as a complete divestment rather than an internal reporting realignment could lead to incorrect market assumptions.

Future Outlook

The filing indicates that certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately, pursuing the same investment strategies as previously.

Management Comments

• The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard for institutional investors reporting passive beneficial ownership. This amendment highlights how large asset managers like The Vanguard Group manage their internal reporting structures, which can impact how their aggregate holdings are publicly disclosed, even if the underlying investment strategy remains consistent across their various entities.

Stakeholder Impact

• Shareholders of Elevance Health Inc. may see a change in the reported beneficial ownership by The Vanguard Group, though the underlying investment by Vanguard's various entities is expected to continue.
• Investment professionals tracking institutional ownership will need to account for the disaggregated reporting from Vanguard's subsidiaries.

Next Steps

• Certain subsidiaries or business divisions of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.

Key Dates

Keywords

Schedule 13G, Elevance Health Inc, Vanguard Group, beneficial ownership, internal realignment, institutional investor, SEC filing, common stock